Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialDanny Rischin, Grant A. McArthur, Richard J. Young et al.|Journal of Clinical Oncology|2010Cited by 741
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu‐Pei Chen, Nofisat Ismaila, Melvin L.K. Chua et al.|Journal of Clinical Oncology|2021Cited by 393
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinomaAnne W.M. Lee, Joseph Wee, Wai Tong Ng et al.|Radiotherapy and Oncology|2017Cited by 374
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A. Forastiere, Gregory T. Wolf, Nofisat Ismaila et al.|Journal of Clinical Oncology|2017Cited by 366
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid Thomson, Sue S. Yom, Nancy Y. Lee et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 211